Pharmaceutical Products Companies By Roe
LargestBiggest EarnersMost ProfitableMost LiquidHighly LeveragedTop DividendsCapital-HeavyHighest ValuationLargest Workforce
Return On Equity
| Return On Equity | Efficiency | Market Risk | Exp Return | ||||
|---|---|---|---|---|---|---|---|
| 1 | VYGR | Voyager Therapeutics | 0.03 | 4.29 | 0.13 | ||
| 2 | HROWL | Harrow Health 8625 | 0.14 | 0.50 | 0.07 | ||
| 3 | VRTX | Vertex Pharmaceuticals | (0.16) | 1.13 | (0.18) | ||
| 4 | XOMAP | XOMA Corp | 0.03 | 0.56 | 0.02 | ||
| 5 | XOMAO | XOMA Corporation | 0.06 | 0.54 | 0.03 | ||
| 6 | EGRX | Eagle Pharmaceuticals | (0.06) | 5.28 | (0.30) | ||
| 7 | VNDA | Vanda Pharmaceuticals | 0.09 | 6.27 | 0.55 | ||
| 8 | VTRS | Viatris | 0.00 | 1.71 | 0.00 | ||
| 9 | DNTH | Dianthus Therapeutics | 0.06 | 4.83 | 0.27 | ||
| 10 | CDTTW | Conduit Pharmaceuticals | 0.19 | 41.83 | 8.13 | ||
| 11 | SAVAW | Cassava Sciences Warrant | (0.12) | 17.44 | (2.10) | ||
| 12 | ELAB | Elevai Labs | 0.04 | 5.61 | 0.20 | ||
| 13 | CEROW | CERo Therapeutics Holdings | 0.11 | 28.30 | 3.25 | ||
| 14 | NWBO | Northwest Biotherapeutics | (0.04) | 3.96 | (0.16) | ||
| 15 | FBLG | FibroBiologics Common Stock | (0.04) | 15.81 | (0.62) | ||
| 16 | HROWM | Harrow Health 11875 | 0.07 | 0.66 | 0.05 | ||
| 17 | MGX | Metagenomi Common Stock | (0.17) | 5.99 | (1.03) | ||
| 18 | PBM | PSYENCE BIOMEDICAL LTD | 0.00 | 0.00 | 0.00 | ||
| 19 | SER | Serina Therapeutics | (0.10) | 9.00 | (0.90) | ||
| 20 | QTTB | Q32 Bio | 0.29 | 5.22 | 1.50 |
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income. For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.